-
2024-512849-17-00
5
2025-11-14
Systemic Autoimmune Rheumatic Diseases associated Interstitial Lung Di
-
2024-517316-29-00
4
2025-11-07
Unresectable stage III Non-Small Cell Lung Cancer
-
2024-519917-72-00
5
2025-10-29
Transthyretin Amyloidosis with Cardiomyopathy (ATTR Amyloidosis with C
-
2025-521188-11-00
5
2025-10-15
Type 2 diabetes
-
2024-516652-18-00
5
2025-10-10
Atherosclerotic cardiovascular disease (ASCVD) and obesity or overweig
-
2024-517671-21-00
5
2025-09-30
Coronavirus Disease 2019 (COVID-19)
-
2024-512177-27-01
5
2025-09-29
High-risk Bacillus Calmette-Guerin (BCG)-unresponsive non-muscle-invas
-
2025-520740-16-00
5
2025-09-19
Primary Aldosteronism defined by excess aldosterone secretion
-
2024-517525-10-00
4
2025-09-15
APOL1 Kidney Disease (AKD)
-
2025-520519-14-00
5
2025-09-03
Atherosclerotic Cardiovascular Disease
-
2024-518154-16-00
5
2025-08-27
non-small cell lung cancer
-
2024-519052-82-00
4
2025-06-30
pleural mesothelioma
-
2024-512653-25-00
5
2025-06-26
IgA nephropathy
-
2024-519219-32-00
5
2025-06-23
Heart Failure With Reduced Ejection Fraction
-
2024-519991-18-00
6
2025-06-16
Rheumatoid Arthritis
-
2024-517457-27-00
5
2025-06-04
Chronic Obstructive Pulmonary Disease (COPD)
-
2024-511828-14-00
4
2025-05-13
Type II diabetes melittus (10067585)
-
2024-513959-33-00
4
2025-05-13
Asthma
-
2023-506460-14-00
5
2025-05-07
Chronic kidney disease (CKD) and hypertension.
-
2023-507613-10-01
7
2025-03-31
Active Systemic Lupus Erythematosus;Systemic lupus erythematosus (SLE)
-
2023-508798-94-00
5
2025-02-11
Heart failure
-
2024-511442-39-00
5
2025-02-05
Rheumatoid arthritis (RA)
-
2024-512900-20-00
7
2025-01-30
Non-muscle invasive bladder cancer (NMIBC)
-
2024-516372-14-00
11
2025-01-13
Asymptomatic Patients with frequent PVCs and normal LVEF